Sotera Health Company Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Sotera Health Company stock has a consensus rating of "Buy" and an average price target of $20.22. The average 1-year stock price forecast is 27.69% higher than the current stock price, while the lowest is $16 (+1.04%) and the highest is $24 (+51.56%).

Price Target: $20.22 (+27.69%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$16	$20.22	$20	$24
Change	+1.04%	+27.69%	+26.30%	+51.56%

Analyst Ratings

The average analyst rating for Sotera Health Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	5	5	5	5	5	5
Buy	3	3	3	3	3	3
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	10	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Bednar Piper Sandler	Piper Sandler	Buy Maintains $22	Buy	Maintains	$22	+38.93%	Jun 10, 2026
Evie Koslosky Goldman Sachs	Goldman Sachs	Buy Initiates $20	Buy	Initiates	$20	+26.30%	Jun 5, 2026
Patrick B Donnelly Citi	Citi	Buy Maintains $23	Buy	Maintains	$23	+45.25%	May 28, 2026
Ryan Halsted RBC Capital	RBC Capital	Buy Reiterates $24	Buy	Reiterates	$24	+51.56%	May 22, 2026
Sean Dodge BMO Capital	BMO Capital	Buy Reiterates $20	Buy	Reiterates	$20	+26.30%	May 6, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.24B

from 1.16B

6.65%

from 1.16B

Revenue Next Year

1.31B

from 1.24B

5.91%

from 1.24B

EPS This Year

0.97

from 0.86

12.73%

from 0.86

EPS Next Year

1.06

from 0.97

9.66%

from 0.97

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	931.48M	1.00B	1.05B	1.10B	1.16B	1.24B
Revenue Growth	13.85%	7.75%	4.54%	4.88%	5.74%	6.65%
Gross Profit	518.67M	557.00M	577.16M	602.30M	645.53M	732.71M
Gross Margin	55.68%	55.50%	55.00%	54.73%	55.48%	59.04%
Operating Income	305.53M	327.89M	326.99M	335.51M	414.33M	529.42M
Net Income	116.88M	-233.57M	51.38M	44.40M	77.95M	201.21M
EPS	-	-	-	-	0.86	0.97
EPS Growth	-	-	-	-	22.86%	12.73%
Forward PE	24.18	8.38	18.81	18.03	19.12	16.33
Free Cash Flow	209.75M	570.85M	-283.16M	107.30M	236.80M	119.81M
No. Analysts	-	-	-	-	-	9

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	1.2B
Avg	1.2B
Low	1.2B

Revenue Growth

Revenue Growth	2026	2027	2028
High	6.8%
Avg	6.7%
Low	6.2%

EPS Forecast

EPS	2026	2027	2028
High	1.00
Avg	0.97
Low	0.95

EPS Growth

EPS Growth	2026	2027	2028
High	16.3%
Avg	12.7%
Low	10.0%